Mechanisms of the increased pressor response to vasopressors in the mesenteric bed of nitric oxide-deficient hypertensive rats

被引:25
作者
Ruiz-Marcos, FM [1 ]
Ortíz, MC [1 ]
Fortepiani, LA [1 ]
Nadal, FJA [1 ]
Atucha, NM [1 ]
García-Estañ, J [1 ]
机构
[1] Fac Med, Dept Fisiol, Murcia 30100, Spain
关键词
nitric oxide (NO); vascular reactivity; arterial hypertension; methoxamine; acetylcholine; EDHF (endothelium-dependent hyperpolarizing; factor);
D O I
10.1016/S0014-2999(00)00795-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present study we analyzed mesenteric vascular reactivity of chronic nitric oxide (NO)-deficient hypertensive rats (N-W-nitro-L-Arginine Methyl Ester, L-NAME, 50 mg/kg/day, oral, 3 weeks). Perfusion pressure changes in response to cumulative additions of methoxamine and KCI were significantly increased in the mesenteric vessels of the L-NAME-treated as compared with vessels of the controls. Verapamil reduced the responses to methoxamine, but those of the hypertensive rats were still enhanced. In contrast, responses to KCl were almost completely abolished by verapamil. In mesenteric vessels perfused with zero calcium and high-potassium Krebs, presser responses to the re-addition of calcium were also significantly enhanced in the hypertensive rats compared to the controls. Vasodilator responses to acetylcholine in KCl-preconstricted vessels, while still significant, were reduced in the L-NAME-treated rats. In this case, acute inhibition of NO blocked the vasodilator responses to acetylcholine and abolished the differences between the two groups. In methoxamine-preconstricted vessels and in the presence of acute inhibition of NO and prostaglandins, vasodilator responses to acetylcholine were significantly greater in the hypertensive vessels than in controls. In conclusion, the mesenteric vessels of L-NAME hypertensive rats show an enhanced response to vasopressors which is related to calcium entry. These data also reveal the existence of an enhanced role of a NO and prostaglandin-independent vasodilator factor, probably endothelium-derived hyperpolarizing factor that may play a compensatory role in the deficiency of NO. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:273 / 279
页数:7
相关论文
共 23 条
[1]   VARYING EXTRACELLULAR [K+] - A FUNCTIONAL-APPROACH TO SEPARATING EDHF-RELATED AND EDNO-RELATED MECHANISMS IN PERFUSED RAT MESENTERIC ARTERIAL BED [J].
ADEAGBO, ASO ;
TRIGGLE, CR .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 21 (03) :423-429
[2]   Role of protein kinase C in mesenteric pressor responses of rats with portal hypertension [J].
Atucha, NM ;
Ortiz, MC ;
Martinez, C ;
Quesada, T ;
GarciaEstan, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (02) :277-282
[3]   COMPARISON OF EFFECTS OF CHRONIC AND ACUTE ADMINISTRATION OF N-G-NITRO-L-ARGININE METHYL-ESTER TO THE RAT ON INHIBITION OF NITRIC OXIDE-MEDIATED RESPONSES [J].
BRYANT, CE ;
ALLCOCK, GH ;
WARNER, TD .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (08) :1673-1679
[4]   DIFFERENCES IN SENSITIVITY OF RAT MESENTERIC SMALL ARTERIES TO AGONISTS WHEN STUDIED AS RING PREPARATIONS OR AS CANNULATED PREPARATIONS [J].
BUUS, NH ;
VANBAVEL, E ;
MULVANY, MJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (02) :579-587
[5]   ACETYLCHOLINE RELEASES ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR AND EDRF FROM RAT-BLOOD VESSELS [J].
CHEN, G ;
SUZUKI, H ;
WESTON, AH .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (04) :1165-1174
[6]   EFFECT OF HYPERTENSION INDUCED BY NITRIC-OXIDE SYNTHASE INHIBITION ON STRUCTURE AND FUNCTION OF RESISTANCE ARTERIES IN THE RAT [J].
DENG, LY ;
THIBAULT, G ;
SCHIFFRIN, EL .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 1993, 15 (03) :527-537
[7]   Vascular reactivity in mesenteric resistance arteries following chronic nitric oxide synthase inhibition in Wistar rats [J].
Dowell, FJ ;
Henrion, D ;
Duriez, M ;
Michel, JB .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (02) :341-346
[8]  
FERNANDEZRIVAS A, 1995, J HYPERTENS, V13, P123
[9]  
GarciaEstan J, 1996, KIDNEY INT, pS141
[10]   In vitro alteration of aortic vascular reactivity in hypertension induced by chronic NG-nitro-L-arginine methyl ester [J].
Henrion, D ;
Dowell, FJ ;
Levy, BI ;
Michel, JB .
HYPERTENSION, 1996, 28 (03) :361-366